Analysis of Ultra-Low Temperature Freezer Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global ultra-low temperature freezer market size is calculated at a size of US$ 581.6 million in 2024 and is projected to expand at a CAGR of 4.4% to reach US$ 894.5 million by 2034-end.
The COVID-19 pandemic influenced this market in a big way. Due to the pandemic, there was an exorbitant increase in blood & blood component demand throughout the globe, thereby boosting sales of ultra-low temperature (ULT) freezers. The COVID-19 pandemic also increased the importance of adequate storage facilities among all end users.
Growing research & development activities and government support for the clinical trials of chronic and infectious disease drugs are proving to be propellers for global ultra-low temperature freezer market growth. Increasing importance of energy efficiency and sustainability are some of the ultra-low temperature freezer market trends driving the demand for eco-friendly cooling solutions.
| Report Attribute | Detail |
|---|---|
| Ultra-Low Temperature Freezer Market Size (2024E) | US$ 581.6 Million |
| Forecasted Market Value (2034F) | US$ 894.5 Million |
| Global Market Growth Rate (2024 to 2034) | 4.4% CAGR |
| South Korea Market Value (2034F) | US$ 47.7 Million |
| Upright Ultra-low Temperature Freezer Demand Growth Rate (2024 to 2034) | 4.1% CAGR |
| Key Companies Profiled | Bionics Scientific Technologies (P) Ltd; Glen Dimplex; Haier Biomedical; Thermo Fisher Scientific; Arctiko A/S; Eppendorf AG; BINDER GmbH; Azbil Corporation; Panasonic Healthcare Corporation; BioLife Solutions Inc.; PHC Corporation; LABCOLD; Remi Group; Helmer Scientific Inc. |
“ULT Freezers Crucial for Storage and Transportation of Blood During Emergencies”
Blood transfusion is considered a supportive therapy for surgery, chemotherapy, and organ transplantation, along with the treatment of acute and chronic diseases. Blood loss due to any specific disease or accident also affects one health.
Cancer-related procedures and pregnancy complications require a severe call for blood transfusion. The ULT freezers and vans play an important role in ensuring the safe storage and transportation of blood and blood components.
“High Cost of Advanced Ultra-low Temperature Freezing Technologies”
For setting up advanced and adequate ultra-low temperature freezer infrastructure huge capital is required. The hospitals operating on a constrained budget usually avoid the adoption of ultra-low temperature freezer technologies. Such settings opt for alternatives such as dry ice, liquid nitrogen, or biomedical refrigerators.
Several leading companies are investing heavily in the production of automated ultra-low temperature freezers. Automation directly increases the price of these freezers. Thus, the above-mentioned factors are expected to hamper the ultra-low temperature freezer sales growth in the coming years.
“Rising Investments in Genetic Research Increasing Use of Ultra-low Temperature Freezers in the U.S.”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 61.9 Million |
| Growth Rate (2024 to 2034) | 4.8% CAGR |
| Projected Value (2034F) | US$ 99.1 Million |
Presence of key producers of ULT freezers in the United States is primarily supporting the market growth. The country’s focus on the development of precision medicine, high investment in genetic research, and growing demand for personalized medications are further increasing the adoption of advanced ultra-low temperature freezers. The country being first at adopting new technologies is driving its position as the frontrunner in the North American market growth.
“Increasing Healthcare Expenditure Driving Opportunities for Ultra-low Temperature Freezer Suppliers”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 37.6 Million |
| Growth Rate (2024 to 2034) | 4.9% CAGR |
| Projected Value (2034F) | US$ 60.8 Million |
Well-coordinated blood and blood product systems are enhancing the life-saving impact of hospitals and other healthcare settings in Japan. During the COVID-19 pandemic, Japan fell behind in the availability of ultra-low temperature freezers. To overcome this challenge, the government started investing more in advancing healthcare infrastructure, which has subsequently driven up the sales of ultra-low temperature freezers.
“Increasing Cancer Cases and Growing Investments in Cancer Research”
Several clinical trials for developing oncology medicines are taking place in Germany, leading to increasing demand for ultra-low temperature freezers. Germany is one of the most populous countries in Europe and also holds top rank in cancer cases. The increasing number of cancer cases leading to surgeries is set to boost the demand for ultra-low temperature freezers in healthcare settings.
“Preference for Energy-Efficient Chest Ultra-low Temperature Freezers”
| Attribute | Chest Ultra-low Temperature Freezers |
|---|---|
| Segment Value (2024E) | US$ 295.4 Million |
| Growth Rate (2024 to 2034) | 4.7% CAGR |
| Projected Value (2034F) | US$ 466.1 Million |
Chest ultra-low temperature freezers are anticipated to exhibit increasing demand during the forecast period. Chest ULT freezers are highly energy efficient with temperature stability. They can store a high volume of samples. The adoption of chest ULT freezers is increasing due to their rising use in biological sample preservation and long-term specimen storage.
“Large Storage Capacity ULT Freezers Widely Utilized by Biobanks”
| Attribute | Biobanks |
|---|---|
| Segment Value (2024E) | US$ 196.6 Million |
| Growth Rate (2024 to 2034) | 4.1% CAGR |
| Projected Value (2034F) | US$ 294.3 Million |
Biobanks are forecasted to capture 32.9% of the global market share by 2034. Biobanks highly require ultra-low temperature freezers to maintain the viability and stability of valuable specimens such as cells, tissues, and DNA. Rising demand for personalized therapeutics and precision medicine is driving the growth of bio-banks, which is subsequently increasing the adoption of ultra-low temperature freezers.
Key players in of ultra-low temperature freezer market are focused on introducing new product ranges with enhanced freezing capabilities, besides other approaches, including collaborations, partnerships, and acquisitions.
Fact.MR provides detailed information about the price points of key manufacturers of ultra-low temperature freezers positioned across the world, sales growth, production capacity, and speculative technological expansion, in the recently updated market report.
What is the size of the ultra-low temperature freezer market?
The global ultra-low temperature freezer market is estimated at US$ 581.6 million in 2024.
What size will be the ultra-low temperature freezer market reach by 2034?
Sales of ultra-low temperature freezers are projected to reach US$ 894.5 million by 2034.
What is the estimated demand growth for ultra-low temperature freezers?
Demand for ultra-low temperature freezers is forecasted to increase at a CAGR of 4.4% from 2024 to 2034.
Which is a profitable regional market for ultra-low temperature freezer manufacturers?
North America is forecasted to capture 24.3% of the global market share by 2034.
What is the market scenario for ULT freezers in South Korea?
The market in South Korea has been calculated to expand at a CAGR of 5.1% from 2024 to 2034.
Which type of ultra-low temperature freezer is widely utilized?
Chest ultra-low temperature freezer sales are foreseen to reach US$ 466.1 million by 2034.
Who are the top manufacturers of ultra-low temperature freezers?
Key market players are Haier Biomedical, Thermo Fisher Scientific, Arctiko A/S, Eppendorf AG, and BINDER GmbH.
Ultra-Low Temperature Freezer Market